Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia

Phase 3 Unknown 96 enrolled Shandong Lanjin Pharmaceuticals Co.,Ltd

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether bendamustine is effective in the treatment of initial treatment of Chronic Lymphocytic Leukemia (CLL).

Timeline

Start: 2011-01
Primary completion: 2013-10
Completion: 2013-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bendamustine	Small molecule	100 mg/m2	Intravenous
Comparator	Chlorambucil	Other / unclassified	0.4 mg/kg	Oral

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia

Summary

Timeline

Drugs

Indications